Home Featured Page 17

Featured

Latest

Rethinking Addiction and Treatment Models: Is the Recovery Community Ready for Psychedelics?

Psychedelics Today Gifting Guide 2024

The Mystical Roots of Psychedelics: Exploring Dreams and the Liminal State

SCOOP: PSFC’s $130M Roadmap to Shape the Future of Psychedelic Philanthropy

Pα+ Psychedelic Bulletin #183:

Why Are Some Parents Choosing Psychedelics Over SSRIs for Teens?

Natural Medicine Advisory Bulletin 11.5: Rule Review & Roadmap

From the Eleusinian Mysteries to Modern Mysticism: The Role of Religion...

Analysis: FDA Advisory Committee Snubs MDMA-Assisted Therapy for PTSD in Overwhelming...

Exploring Somatic Practices and Psychedelics

The EMBARK Model of Psychedelic Therapy

Live Coverage: FDA Advisory Committee Reviews MDMA-Assisted Therapy for PTSD

ICER Panel Rejects MDMA-Assisted Therapy, Highlights Evidence Gaps and Study Flaws...

How Psychedelics Became Key to My Long COVID Recovery

Rethinking Addiction and Treatment Models: Is the Recovery Community Ready for...

Psychedelics Today Gifting Guide 2024

The Mystical Roots of Psychedelics: Exploring Dreams and the Liminal State

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Rethinking Addiction and Treatment Models: Is the Recovery Community Ready for Psychedelics?

Psychedelics Today Gifting Guide 2024

The Mystical Roots of Psychedelics: Exploring Dreams and the Liminal State

SCOOP: PSFC’s $130M Roadmap to Shape the Future of Psychedelic Philanthropy

Pα+ Psychedelic Bulletin #183:

Why Are Some Parents Choosing Psychedelics Over SSRIs for Teens?

Natural Medicine Advisory Bulletin 11.5: Rule Review & Roadmap

From the Eleusinian Mysteries to Modern Mysticism: The Role of Religion...

Analysis: FDA Advisory Committee Snubs MDMA-Assisted Therapy for PTSD in Overwhelming...

Exploring Somatic Practices and Psychedelics

The EMBARK Model of Psychedelic Therapy

Live Coverage: FDA Advisory Committee Reviews MDMA-Assisted Therapy for PTSD

ICER Panel Rejects MDMA-Assisted Therapy, Highlights Evidence Gaps and Study Flaws...

How Psychedelics Became Key to My Long COVID Recovery

Long COVID and Psychedelics

EDITOR PICKS

Rethinking Addiction and Treatment Models: Is the Recovery Community Ready for...

Psychedelics Today Gifting Guide 2024

The Mystical Roots of Psychedelics: Exploring Dreams and the Liminal State

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY